Skip to content
value.today

Naurex Inc.

🇺🇸 Evanston, Illinois, USABiotechnologyFounded 2006

Formerly Nyxis Neurotherapies, Inc.

Total raised
$154 M
4 rounds on record
Latest round
$80 M
Nov 2014
First round on record
May 2011
Today
Private
No later event on record

Funding rounds

4 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Naurex Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Nov 2014$80 MNo. 4$50 to $250 million

Naurex Inc.: Raise no. 4, Nov 2014

Investors in this round

61 investors had bought by the notice of Dec 3, 2014: 61 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$80 M (amount offered: indefinite)
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Ashish M. Khanna · Executive Officer
  • James M. Schulz · Executive Officer
  • Joseph R. Moskal · Executive Officer
  • Mitchell S. Bloom · Executive Officer
  • Mohamed Amin Khan · Executive Officer
  • Norbert G. Riedel · Executive Officer, Director
  • Ronald M. Burch · Executive Officer
  • Derek A. Small · Director
  • Ian R. Ferrier · Director
  • Kenneth J. Widder · Director
  • Robert J. Hombach · Director
  • Terry P. Gould · Director
  • Wilbur H. Gantz · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Amount sold in item 13 includes $7,914,739 from 8 non-US investors. Number of investors in item 14 includes 8 non-US investors.”
  • On the use of proceeds: “The Issuer will use proceeds for general working capital purposes, which includes payments to its executive officers and other employees in the ordinary course of business.”

Signed by James S. Schulz, Treasurer & Chief Financial Officer. Source: SEC Form D, newest notice filed Dec 3, 2014. Read the notice at the SEC.

equitySEC
May 2014$25 MNo. 3$10 to $50 million

Naurex Inc.: Raise no. 3, May 2014

Investors in this round

40 investors had bought by the notice of May 14, 2014: 40 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$25 M (amount offered: indefinite)
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Amin M. Khan · Executive Officer
  • Ashish M. Khanna · Executive Officer
  • James M. Schulz · Executive Officer
  • Joseph R. Moskal · Executive Officer
  • Mitchell S. Bloom · Executive Officer
  • Norbert Riedel · Executive Officer, Director
  • Ronald M. Burch · Executive Officer
  • Ian H. Ferrier · Director
  • Kenneth J. Widder · Director
  • Robert J. Hombach · Director
  • Terry Gould · Director
  • Wilbur H. Gantz · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “The Issuer will use proceeds for general working capital purposes, which includes payments to its executive officers and other employees in the ordinary course of business.”

Signed by James Schulz, Treasurer & Chief Financial Officer. Source: SEC Form D, newest notice filed May 14, 2014. Read the notice at the SEC.

equitySEC
Dec 2012$38 MNo. 2$10 to $50 million

Naurex Inc.: Raise no. 2, Dec 2012

Investors in this round

31 investors had bought by the notice of Dec 21, 2012: 31 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$38 M of $38 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Amin M. Khan · Executive Officer
  • Ashish M. Khanna · Executive Officer
  • Derek Small · Executive Officer, Director
  • James M. Schulz · Executive Officer
  • Jaswant S. Gidda · Executive Officer
  • Joseph R. Moskal · Executive Officer
  • Mitchell S. Bloom · Executive Officer
  • Ronald M. Burch · Executive Officer
  • Ian H. Ferrier · Director
  • Kenneth J. Widder · Director
  • Norbert C. Riedel · Director
  • Terry Gould · Director
  • Wilbur H. Gantz · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Amount sold includes $2,333,600 from 3 non-US investors. Number of investors in Item 14 includes 3 non-US investors.”
  • On the use of proceeds: “The Issuer will use proceeds for general working capital purposes, which includes payments to its executive officers and other employees in the ordinary course of business.”

Signed by Derek Small, Chief Executive Officer. Source: SEC Form D, newest notice filed Dec 21, 2012. Read the notice at the SEC.

equitySEC
May 2011$11 MNo. 1$10 to $50 million

Naurex Inc.: Raise no. 1, May 2011

Investors in this round

43 investors had bought by the notice of May 19, 2011: 43 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$11 M (amount offered: indefinite)
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Amin M. Khan · Executive Officer
  • Ashish M. Khanna · Executive Officer
  • Derek Small · Executive Officer, Director
  • James M. Schulz · Executive Officer
  • Joseph R. Moskal · Executive Officer
  • Mitchell S. Bloom · Executive Officer
  • Ronald M. Burch · Executive Officer
  • David C. U'Prichard · Director
  • Edward J. Chandler · Director
  • Kenneth J. Widder · Director
  • Terry Gould · Director
  • Wilbur H. Gantz · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “The total amount sold includes the conversion of certain promissory notes.”
  • On the use of proceeds: “The Issuer will use proceeds for general working capital purposes, which includes payments to its executive officers and other employees in the ordinary course of business.”

Signed by Derek Small, Active Chief Executive Officer. Source: SEC Form D, newest notice filed May 19, 2011. Read the notice at the SEC.

equity, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Naurex Inc. chose not to state its revenue in its newest notice of a funding round (Dec 2014).

    SEC Form D · Dec 2014

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Dec 2014

That is all the official record says: Naurex Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Naurex Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 4 rounds above had up to 61 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Naurex Inc.
NameRoleNamed in
Ashish M. KhannaExecutive officerDec 2014
James M. SchulzExecutive officerDec 2014
Joseph R. MoskalExecutive officerDec 2014
Mitchell S. BloomExecutive officerDec 2014
Mohamed Amin KhanExecutive officerDec 2014
Norbert G. RiedelExecutive officerDec 2014
Ronald M. BurchExecutive officerDec 2014
Amin M. KhanExecutive officerMay 2014
Norbert RiedelExecutive officerMay 2014
Derek SmallExecutive officerDec 2012
Jaswant S. GiddaExecutive officerDec 2012
Derek A. SmallDirectorDec 2014
Ian R. FerrierDirectorDec 2014
Kenneth J. WidderDirectorDec 2014
Norbert G. RiedelDirectorDec 2014
Robert J. HombachDirectorDec 2014
Terry P. GouldDirectorDec 2014
Wilbur H. GantzDirectorDec 2014
Ian H. FerrierDirectorMay 2014
Norbert RiedelDirectorMay 2014
Terry GouldDirectorMay 2014
Derek SmallDirectorDec 2012
Norbert C. RiedelDirectorDec 2012
David C. U'PrichardDirectorMay 2011
Edward J. ChandlerDirectorMay 2011